Page last updated: 2024-08-23

2-amino-3-methylimidazo(4,5-f)quinoline and Thyroid Neoplasms

2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with Thyroid Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asamoto, M; Inoue, T; Ito, N; Nagao, M; Ogiso, T; Tsuda, H1

Other Studies

1 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and Thyroid Neoplasms

ArticleYear
Dose-dependent induction of liver and thyroid neoplastic lesions by short-term administration of 2-amino-3-methylimidazo[4,5-f]quinoline combined with partial hepatectomy followed by phenobarbital or low dose 3'-methyl-4-dimethylaminoazobenzene promotion.
    Japanese journal of cancer research : Gann, 1988, Volume: 79, Issue:6

    Topics: 2-Acetylaminofluorene; Animals; Cocarcinogenesis; Dose-Response Relationship, Drug; Hepatectomy; Liver Neoplasms, Experimental; Methyldimethylaminoazobenzene; Mutagens; Phenobarbital; Quinolines; Rats; Rats, Inbred F344; Thyroid Neoplasms

1988